ADAMS ROBERT G - 15 Dec 2023 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Director
Signature
/s/ Robert G. Adams, by Kristina R. Hulsey, POA
Issuer symbol
NHC
Transactions as of
15 Dec 2023
Net transactions value
+$108
Form type
4
Filing time
18 Dec 2023, 16:39:52 UTC
Previous filing
03 Nov 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Shares of Common Stock - Trust I Options Exercise $584,400 +7,500 +247% $77.92 10,534 15 Dec 2023 Trustee F1
transaction NHC Shares of Common Stock - Trust I Tax liability $584,385 -6,203 -59% $94.21 4,331 15 Dec 2023 Trustee F2
transaction NHC Shares of Common Stock - Trust I Options Exercise $359,786 +5,566 +129% $64.64 9,897 15 Dec 2023 Trustee F3
transaction NHC Shares of Common Stock - Trust I Tax liability $359,694 -3,818 -39% $94.21 6,079 15 Dec 2023 Trustee F2, F4
holding NHC Shares of Common Stock - Partnership 430,341 15 Dec 2023 General Partner

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Options Exercise $0 -7,500 -100% $0.000000* 0 15 Dec 2023 Common Stock 7,500 $77.92 Direct F1
transaction NHC Option to Purchase Common Stock [2020 Grant] Options Exercise $0 -5,566 -100% $0.000000* 0 15 Dec 2023 Common Stock 5,566 $64.64 Direct F3
holding NHC Option to Purchase Common Stock [2021 Grant] 7,500 15 Dec 2023 Common Stock 7,500 $71.64 Direct
holding NHC Option to Purchase Common Stock [2022 Grant] 7,500 15 Dec 2023 Common Stock 7,500 $69.19 Direct
holding NHC Option to Purchase Common Stock [2023 Grant] 7,500 15 Dec 2023 Common Stock 7,500 $55.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 Shares were withheld by the Company to pay the exercise price.
F3 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F4 Total amount of shares beneficially owned following all transactions reported for the Title of Securities "Shares of Common Stock - Trust I" on this form.